What it can tell you, and nothing else can:
- Solvency and survivability (Question 4 of the five): how much debt, due when, against what liquidity. Every corporate collapse you'll autopsy in Phase 2 (IL&FS, DHFL, Lehman) was a balance-sheet death. The liabilities were due today, and the assets could only become cash tomorrow.
- Capital intensity: how many rupees of assets it takes to produce a rupee of sales. Compare Asian Paints' ₹29,100 crore balance sheet generating ~₹35,000 crore of revenue with an IT-services company generating the same revenue off a third of the assets. This becomes ROIC's denominator in the returns-on-capital module ahead, and ROIC is the quality metric of the whole program.
- The funding mix: owners' money vs lenders' vs float (suppliers, customers, deferred tax). Fragility and financing cost are decided by this mix.
- The autobiography: the equity section tells you whether the business self-funded, diluted, or returned capital, with decades compressed into six lines.
Advertisement
What can't a balance sheet tell you?
What it cannot tell you:
- What the company is worth. Book value is historical cost filtered through depreciation conventions and conservatism, not market value. Asian Paints' book equity of ~₹19,000 crore has coexisted with a market capitalization ten to fifteen times larger (as of mid-2026). Most banks trade near 1–2× book. The gap is information. A P/B of 12 says the market believes each rupee of book capital creates ~₹12 of value. Below 1, that capital is being destroyed, or the book is wrong. The module on relative valuation turns this into algebra:
P/B ≈ (ROE − g)/(r − g). - The most valuable assets of modern businesses. Internally generated brands, in-house software (US GAAP expenses R&D as incurred), trained people, distribution, network effects: all invisible. Accounting capitalizes only what was bought in a transaction. The proof is almost absurd. If Company A buys Company B's brand, it appears on A's balance sheet, while the identical home-grown brand appears nowhere on B's. Coca-Cola's brand, among the most valuable objects on earth, is absent from Coca-Cola's balance sheet. It follows that asset-light compounders show tiny book values and stratospheric ROEs partly as an accounting artifact. Never compare P/B across business models without remembering it.
- Asymmetric truth. Conservatism writes assets down when they sour but almost never up when they bloom. US GAAP never does, and Ind AS/IFRS allow only the rare revaluation option. Land bought in 1965 stays at 1965 cost. The book tells you the bad news and keeps quiet about the good.
- The other 364 days. It's one posed photograph. Quarter-end debt paydowns, receivable sales and shipment timing all dress the frame.
- Off-balance-sheet exposures. Contingent liabilities, guarantees for group companies (an Indian promoter-group specialty) and purchase commitments are in the notes, not the totals. The visible balance sheet is a floor on obligations. It isn't a ceiling.
How should an analyst use the balance sheet?
So where does a mature analyst land? The balance sheet is the most reliable statement. It has to balance and roll forward, so it's the hardest to fake outright. It's also the least complete, blind to the intangibles that increasingly are the business. Read it first for safety and capital intensity. Read the P&L and cash flows for performance, and the notes for everything the totals hide.